This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Biomodal Limited, Cambridge Epigenetix Limited. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: David Morley: Innovator in Nucleic Acid Analysis
Introduction
David Morley is a prominent inventor based in St. Albans, GB. He has made significant contributions to the field of nucleic acid analysis, particularly through his innovative methods and systems. His work is essential for advancing genetic research and diagnostics.
Latest Patents
David Morley holds a patent for "Methods for analyzing nucleic acids." This patent provides methods, systems, and compositions for determining a base in a polynucleotide. The techniques described are particularly useful for performing 4-base, 5-base, or 6-base sequencing of polynucleotide molecules. This is especially relevant for analyzing samples from liquid biopsies or identifying low-frequency mutations.
Career Highlights
Morley is associated with Cambridge Epigenetix Limited, a company that focuses on epigenetic research and technology. His work at the company has positioned him as a key figure in the development of innovative solutions for genetic analysis.
Collaborations
David Morley has collaborated with notable scientists such as Shankar Balasubramanian and Jens Fullgrabe. These partnerships have further enhanced the impact of his research and innovations in the field.
Conclusion
David Morley's contributions to nucleic acid analysis through his patent and work at Cambridge Epigenetix Limited highlight his role as an influential inventor in the scientific community. His innovative methods continue to pave the way for advancements in genetic research and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile